Carregant...
Depression Levels and Interferon Treatment in People with Multiple Sclerosis
Multiple sclerosis (MS) is the most common cause of neurologic disease in young and middle-aged adults, and 75% of patients are female. Nearly one in two patients with MS will experience clinically significant depression—approximately three times the prevalence rate in the general population. This s...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
The Consortium of Multiple Sclerosis Centers
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3882981/ https://ncbi.nlm.nih.gov/pubmed/24453727 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7224/1537-2073-14.1.10 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|